Clinical Partnerships Target hospitals, clinics, and physician groups in Michigan and Texas that frequently require DME for lymphedema, bone growth stimulation, PAD management, and CPM therapies. Position Lytle Medical Technologies as a turnkey partner handling insurance verification, authorizations, and patient education to reduce administrative burden and speed equipment delivery.

Expansion Opportunities Leverage geographic footprint in Michigan and Texas to pursue new healthcare networks, durable medical equipment distributors, and rehab facilities. Highlight end‑to‑end service, ACHC accreditation, and a patient‑centered model as differentiators to win contracts with multi‑site systems.

Value Proposition Emphasize cost‑efficiency, faster patient readiness, and improved outcomes through specialized devices (lymphedema garments, bone growth stimulators, CPM, cold therapy, and clot prevention). Offer bundled service agreements that include device maintenance, training, and ongoing clinical documentation review.

Operational Synergy Promote integration capabilities with existing EHR and case management workflows by underscoring dedicated insurance support and clinical documentation review. Position as a low‑hurdle vendor with streamlined onboarding for care teams, reducing time to patient device deployment.

Growth Through Data Highlight potential for value‑based discussions by collecting outcomes data from DME therapies. Propose pilot programs or outcomes reporting packages to payors and providers that demonstrate improved mobility and independence, supporting broader reimbursement and expanded device adoption.